Evidence map›Paper›PMID 18549242›Full record

ArticleBiochemistry2008

The regulatory beta subunit of phosphorylase kinase interacts with glyceraldehyde-3-phosphate dehydrogenase.

Igor G Boulatnikov, Owen W Nadeau, Patrick J Daniels, Jessica M Sage, Marina D Jeyasingham, Maria T Villar, Antonio Artigues, Gerald M Carlson

Abstract read
In one paragraph

Article in Biochemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Igor G BoulatnikovDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
Owen W Nadeau
Patrick J Daniels
Jessica M Sage
Marina D Jeyasingham
Maria T Villar
Antonio Artigues
Gerald M Carlson
University of Kansas Medical Center · USUniversity of Kansas · US

Funding

SUBUNIT INTERACTIONS OF PHOSPHORYLASE KINASER01DK032953 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI CARLSON, GERALD M · 1986 to 2013
$4.6M
The Glycoside Hydrolase Activity of Phosphorylase KinaseR56DK032953 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CARLSON, GERALD M · 2009 to 2014
$609k
NIDDK NIH HHS DK32953NIDDK NIH HHS R01 DK032953NIDDK NIH HHS R56 DK032953
6 · The paper itself

Abstract

Skeletal muscle phosphorylase kinase (PhK) is an (alphabetagammadelta) 4 hetero-oligomeric enzyme complex that phosphorylates and activates glycogen phosphorylase b (GP b) in a Ca (2+)-dependent reaction that couples muscle contraction with glycogen breakdown. GP b is PhK's only known in vivo substrate; however, given the great size and multiple subunits of the PhK complex, we screened muscle extracts for other potential targets. Extracts of P/J (control) and I/lnJ (PhK deficient) mice were incubated with [gamma- (32)P]ATP with or without Ca (2+) and compared to identify potential substrates. Candidate targets were resolved by two-dimensional polyacrylamide gel electrophoresis, and phosphorylated glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was identified by matrix-assisted laser desorption ionization mass spectroscopy. In vitro studies showed GAPDH to be a Ca (2+)-dependent substrate of PhK, although the rate of phosphorylation is very slow. GAPDH does, however, bind tightly to PhK, inhibiting at low concentrations (IC 50 approximately 0.45 microM) PhK's conversion of GP b. When a short synthetic peptide substrate was substituted for GP b, the inhibition was negligible, suggesting that GAPDH may inhibit predominantly by binding to the PhK complex at a locus distinct from its active site on the gamma subunit. To test this notion, the PhK-GAPDH complex was incubated with a chemical cross-linker, and a dimer between the regulatory beta subunit of PhK and GAPDH was formed. This interaction was confirmed by the fact that a subcomplex of PhK missing the beta subunit, specifically an alphagammadelta subcomplex, was unable to phosphorylate GAPDH, even though it is catalytically active toward GP b. Moreover, GAPDH had no effect on the conversion of GP b by the alphagammadelta subcomplex. The interactions described herein between the beta subunit of PhK and GAPDH provide a possible mechanism for the direct linkage of glycogenolysis and glycolysis in skeletal muscle.

Indexed as

AnimalsCalciumCross-Linking ReagentsEnzymes, ImmobilizedGlyceraldehyde-3-Phosphate DehydrogenasesHydrogen-Ion ConcentrationMiceMuscle, SkeletalPhosphorylase KinasePhosphorylationProtein BindingProtein SubunitsRabbitsSuccinimidesTissue ExtractsCalciumCross-Linking ReagentsEnzymes, ImmobilizedGlyceraldehyde-3-Phosphate DehydrogenasesN-(gamma-maleimidobutyryloxy)succinimidePhosphorylase KinaseProtein SubunitsSuccinimidesTissue Extracts

Identifiers

PMID18549242
PMCPMC3674776
OpenAlexW2052269250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.